Agile Therapeutics – This Women’s Healthcare Company’s “Skinfusion” Technology Sets It Apart From Other Contraceptive Companies - Agile Therapeutics (OTC:AGRX)

Al Altomari, Chairman & CEO of Agile Therapeutics AGRX was recently interviewed by Benzinga.

Agile Therapeutics is a women's healthcare company dedicated to fulfilling the unmet health needs of today’s women. Its product and product candidates are designed to provide women with contraceptive options that offer freedom from taking a daily pill, without committing to a longer-acting method.

The company’s initial product, Twirla® (levonorgestrel and ethinyl estradiol) is a transdermal system and a non-daily prescription contraceptive. Twirla is based on the company’s proprietary transdermal patch technology, called Skinfusion®, which is designed to allow drug delivery through the skin.

Agile just raised 7.5$ million in a highly competitive market.

Watch the full interview here:

Featured photo by National Cancer Institute on Unsplash.

This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice.

Market News and Data brought to you by Benzinga APIs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Agile Therapeutics – This Women's Healthcare Company's "Skinfusion" Technology Sets It Apart From Other Contraceptive Companies